Nonvisualization of intravenous methylene blue in patients with clinically normal renal function

Joel, Andrew B.; Mueller, Melanie; Pahira, John J.; Mordkin, Robert

doi:10.1016/s0090-4295(01)01325-5

Cited by 21 publications

(7 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Nedostatak enzima metilen oksidaze omogu~ava olak{anu redukciju methyleneblue u bezbojnu formu leukomethylene-blue pod dejstvom enzima metilen reduktaze 17 . Kasna pojava, svetlozelen-kasta boja urina, kao i produ'eno vreme eliminacije boje usmerili su nas da ispitamo bubre'nu funkciju u na{eg bolesnika koji je primljen radi re{avanja ortopedskog problema.…”

Section: Diskusijaunclassified

Late methylene blue appearance in urine after local treatment of cutaneous fistula in hip osteomyelitis as a firs sign of renal failure

Cvetković

Rosić

et al. 2008

ACTA CHIR IUG

View full text Add to dashboard Cite

Methylene blue is a dark green crystal. In medicine it is used as water or alcohol solution. Methaemoglobinemia, hypotension, septic shock are some of many diseases that are treated with methylene blue. In surgery methylene blue is used in diagnostic procedures such as a fistula detection or detection of the parathyroids glands, and for the delineation of certain body tissues during surgery. In patient with normal renal function methylene blue is appearing in urine in a few minutes after intravenous administration. In our patient who was 70-year-old we remarked interesting phenomena after we instillation methylene blue into the fistila channel during local treatment of hip osteomyelitis. Methylene blue appeared in urine two days after local treatment, coloring the urine light green and color elimination time was prolonged in few days. These parameters induced as to suspect in renal failure. That was prowed after urological, laboratory and radiology examination.

show abstract

Section: Diskusijaunclassified

Late methylene blue appearance in urine after local treatment of cutaneous fistula in hip osteomyelitis as a firs sign of renal failure

Cvetković

Rosić

et al. 2008

ACTA CHIR IUG

View full text Add to dashboard Cite

show abstract

“…MB is cleared renally and has previously been used for macroscopic identification of ureteral leakage and parathyroid glands in high dosages. 7, 18, 19 We have recently demonstrated feasibility of intraoperative visualization of the ureters by NIR fluorescence imaging using low-dose MB during both open and laparoscopic surgeries in Yorkshire pigs. 20 Moreover, NIR imaging has recently shown feasibility in diagnosing ureteropelvic junction obstruction in a swine model.…”

Section: Introductionmentioning

confidence: 99%

Intraoperative Near Infrared Fluorescence Guided Identification of the Ureters Using Low Dose Methylene Blue: A First in Human Experience

et al. 2013

View full text Add to dashboard Cite

Purpose Near-infrared (NIR) fluorescence imaging is a promising technique that offers, real-time, visual information during surgery. The current study reports the first clinical results of ureter imaging using NIR fluorescence after a simple peripheral infusion of methylene blue (MB). Furthermore, optimal timing and dose of MB were assessed. Materials and Methods A total of 12 patients that underwent lower abdominal surgery were included in this prospective feasibility study. NIR fluorescence imaging was performed using the Mini-FLARE™ imaging system. To determine optimal timing and dose, MB was injected intravenously at doses of 0.25, 0.5 or 1 mg/kg, after exposure of the ureters. Subsequently imaging was performed for up to 60 min following injection. Results In all patients both ureters could be clearly visualized within 10 minutes after infusion of MB. Signal lasted at least up to 60 minutes after injection. The mean signal-to-background ratio (SBR) of the ureter was 2.27 ± 1.22 (N = 4), 2.61 ± 1.88 (N = 4) and 3.58 ± 3.36 (N = 4) for the 0.25, 0.5 and 1 mg/kg groups, respectively. A mixed model analysis was used to compare SBRs between dose groups and time points and to assess the relation between dose and time. A significant difference between time points (P < 0.001) was found. However no difference between dose groups was observed (P = 0.811). Conclusions This study demonstrates the first successful use of NIR fluorescence using low-dose MB for the identification of the ureters during lower abdominal surgery.

show abstract

“…17 For example, cystoscopy can be performed with instillation of 10% dextrose (D10) (or 50% dextrose) in sterile water as cystoscopy fluid to take advantage of the difference in viscosity between dextrose and the urine spilling from the ureteral orifice. There are published reports using alternatives to indigo carmine such as oral phenazopyridine HCl 18 and vitamin B complex 19 or intravenous sodium fluorescein 20 and methylene blue [21][22][23] to confirm ureteral patency. But, to our knowledge, there are no previously published data describing the use of D10 as cystoscopy fluid.…”

mentioning

confidence: 99%

Assessing ureteral patency using 10% dextrose cystoscopy fluid: evaluation of urinary tract infection rates

Siff

Unger

Jelovsek

et al. 2016

American Journal of Obstetrics and Gynecology

View full text Add to dashboard Cite

BACKGROUND: Intravenous indigo carmine has routinely been used to confirm ureteral patency after urogynecologic surgery. Recent discontinuation of the dye has altered clinical practice. In the absence of indigo carmine, we have used 10% dextrose in sterile water (D10) as cystoscopic fluid to evaluate ureteral patency. Glucosuria has been associated with urinary tract infection (UTI) in vivo and significantly enhanced bacterial growth in vitro. The concern is that the use of D10 would mimic a state of glucosuria albeit transient and increase the risk of postoperative UTI. OBJECTIVES: The objectives of this study were to compare the rates of postoperative UTI and lower urinary tract (LUT) injuries between patients who underwent instillation of D10 vs normal saline at the time of intraoperative cystoscopy after urogynecological surgery. STUDY DESIGN: This was a retrospective cohort study of all women who underwent cystoscopic evaluation of ureteral patency at the time of urogynecological surgery from May through December 2014 at a tertiary care referral center. We compared patients who received D10 cystoscopy fluid vs those who used normal saline. Outcomes included UTI and diagnosis of ureteral or LUT injuries. UTI was diagnosed according to Centers for Disease Control and Prevention guidelines by symptoms alone, urine dipstick, urinalysis, or urine culture. Descriptive statistics compared

show abstract

Nonvisualization of intravenous methylene blue in patients with clinically normal renal function

Cited by 21 publications

References 5 publications

Late methylene blue appearance in urine after local treatment of cutaneous fistula in hip osteomyelitis as a firs sign of renal failure

Late methylene blue appearance in urine after local treatment of cutaneous fistula in hip osteomyelitis as a firs sign of renal failure

Intraoperative Near Infrared Fluorescence Guided Identification of the Ureters Using Low Dose Methylene Blue: A First in Human Experience

Assessing ureteral patency using 10% dextrose cystoscopy fluid: evaluation of urinary tract infection rates

Contact Info

Product

Resources

About